Similar to ER+, LNN breast cancer patients, stage I colorectal and lung adenocarcinoma are subsets of patients where there is a clinical need to assist the physician in deciding the appropriate level of treatment for the patient. This evidence concerns the gene ESR1 and breast cancer.